title: (68)Ga-PSMA ligand PET versus (18)F-NaF PET: evaluation of response to (223)Ra therapy in a prostate cancer patient.
authors.affiliation: Department of Nuclear Medicine, Medical University Innsbruck, Anichstrasse 35, Innsbruck, Austria, christian.uprimny@uki.at.
authors.forename: Christian
authors.initials: C
authors.lastname: Uprimny
authors.forename: Alexander
authors.initials: A
authors.lastname: Kroiss
authors.forename: Bernhard
authors.initials: B
authors.lastname: Nilica
authors.forename: Sabine
authors.initials: S
authors.lastname: Buxbaum
authors.forename: Clemens
authors.initials: C
authors.lastname: Decristoforo
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Horninger
authors.forename: Irene J
authors.initials: IJ
authors.lastname: Virgolini
mesh_terms: D000328:Adult; D004492:Edetic Acid / Q000031:analogs & derivatives*; D005462:Fluorine Radioisotopes; D005709:Gallium Isotopes; D005710:Gallium Radioisotopes; D006801:Humans; D008297:Male; D009842:Oligopeptides; D049268:Positron-Emission Tomography; D011471:Prostatic Neoplasms / Q000000981:diagnostic imaging* / Q000532:radiotherapy; D019275:Radiopharmaceuticals / Q000627:therapeutic use; D011883:Radium / Q000627:therapeutic use
chemical_list: D005462:Fluorine Radioisotopes; D005709:Gallium Isotopes; D005710:Gallium Radioisotopes; D009842:Oligopeptides; D019275:Radiopharmaceuticals; C000718244:gallium 68 PSMA-11; D004492:Edetic Acid; D011883:Radium